Li Dianming, Liu Zhaofei, Ning Guolan
Department of Respiratory and Critical Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
Department of Respiratory Medicine, Linquan County People's Hospital, Linquan 236400, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Nov 30;40(11):1622-1627. doi: 10.12122/j.issn.1673-4254.2020.11.13.
To investigate the expression of CDC25A in non- small cell lung cancer (NSCLC) tissues and explore its correlation with the clinicpathological features of the patients and the expressions of let-7a1 and let-7c.
We collected surgical specimens of pathologically confirmed NSCLC tissues and paired adjacent lung tissues from 44 patients and tissues of benign lung lesions from 9 patients. The expressions of CDC25A protein and mRNA in the tissues were detected by immunohistochemistry and fluorescence quantitative RT-PCR, respectively; the expressions of let-7a1 and let-7c mRNA were detected using tail-adding fluorescence quantitative RT-PCR.
The positivity rate of CDC25A protein expression was significantly higher in NSCLC tissues than in the adjacent tissues and benign pulmonary lesions ( < 0.05). CDC25A protein expression in NSCLC was not correlated with the patients' age, gender, pathological type, degree of tumor differentiation, or clinical stages ( > 0.05), and was significantly correlated with smoking and lymph node metastasis ( < 0.05). CDC25A mRNA expression was also significantly higher in NSCLC tissues than in the adjacent tissues and benign pulmonary lesions (=6.33, < 0.05), and was similar between the latter two tissues ( > 0.05). Pearson correlation analysis showed that CDC25A expression had a significant negative correlation with let-7c expression in both NSCLC tissues (=-0.42) and adjacent lung tissues (=-0.40) but was not correlated with let-7a1 expression.
The expression level of CDC25A is significantly increased in NSCLC with a negative correlation with Let-7c expression, which identifies CDC25A as a possible downstream target gene of Let-7c.
探讨细胞周期蛋白磷酸酶25A(CDC25A)在非小细胞肺癌(NSCLC)组织中的表达情况,并探究其与患者临床病理特征以及微小RNA-7a1(let-7a1)和微小RNA-7c(let-7c)表达的相关性。
收集44例经病理确诊的NSCLC患者的手术标本及其配对的癌旁肺组织,以及9例肺良性病变组织。分别采用免疫组织化学法和荧光定量逆转录聚合酶链反应(RT-PCR)检测组织中CDC25A蛋白和信使核糖核酸(mRNA)的表达;采用加尾荧光定量RT-PCR检测let-7a1和let-7c mRNA的表达。
NSCLC组织中CDC25A蛋白表达阳性率显著高于癌旁组织和肺良性病变组织(P<0.05)。NSCLC组织中CDC25A蛋白表达与患者年龄、性别、病理类型、肿瘤分化程度或临床分期均无相关性(P>0.05),但与吸烟及淋巴结转移显著相关(P<0.05)。NSCLC组织中CDC25A mRNA表达也显著高于癌旁组织和肺良性病变组织(P=6.33,P<0.05),而后两者之间差异无统计学意义(P>0.05)。Pearson相关性分析显示,NSCLC组织及癌旁肺组织中CDC25A表达与let-7c表达均呈显著负相关(r分别为-0.42和-0.40),但与let-7a1表达无相关性。
NSCLC组织中CDC25A表达水平显著升高,且与Let-7c表达呈负相关,提示CDC25A可能是Let-7c的下游靶基因。